{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:32:30Z","timestamp":1768552350523,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.diagmicrobio.2020.115080","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T22:18:50Z","timestamp":1589581130000},"page":"115080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A coup d'\u00e9tat by NDM-producing Klebsiella pneumoniae overthrows the major bacterial population during KPC-directed therapy"],"prefix":"10.1016","volume":"98","author":[{"given":"Justin R.","family":"Lenhard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amisha P.","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Wenzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry N.","family":"Kreiswirth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zackery P.","family":"Bulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.diagmicrobio.2020.115080_bb0005","doi-asserted-by":"crossref","first-page":"16053","DOI":"10.1038\/nmicrobiol.2016.53","article-title":"Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae","volume":"1","author":"Band","year":"2016","journal-title":"Nat Microbiol"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2020.115080_bb0010","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00091-18","article-title":"Treating polymicrobial infections in chronic diabetic wounds","volume":"32","author":"Buch","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2020.115080_bb0015","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02023-16","article-title":"New polymyxin B dosing strategies to fortify old allies in the war against KPC-2\u2013producing Klebsiella pneumoniae","volume":"61","author":"Bulman","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2020.115080_bb0020","series-title":"Performance standards for antimicrobial susceptibility testing: twenty-ninth informational supplement M100-S29","author":"Clinical and Laboratory Standards Institute","year":"2019"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2020.115080_bb0025","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1378\/chest.121.5.1618","article-title":"Incidence and outcome of polymicrobial ventilator-associated pneumonia","volume":"121","author":"Combes","year":"2002","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2020.115080_bb0030","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1128\/IAI.02198-14","article-title":"Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model","volume":"82","author":"DeLeon","year":"2014","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2020.115080_bb0035","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/JCM.03623-14","article-title":"Four carbapenem-resistant gram-negative species carrying distinct carbapenemases in a single patient","volume":"53","author":"Ding","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2020.115080_bb0040","series-title":"bioMerieux SA. 69280 Marcy-l\u2019Etoile, France","author":"Etest ceftazidime\/avibactam package insert","year":"2017"},{"key":"10.1016\/j.diagmicrobio.2020.115080_bb0045","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s13054-015-1165-5","article-title":"Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome","volume":"19","author":"Ferrer","year":"2015","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2020.115080_bb0050","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/FTD.0000000000000432","article-title":"Therapeutic drug monitoring of gentamicin peak concentrations in critically ill patients","volume":"39","author":"Hodiamont","year":"2017","journal-title":"Ther Drug Monit"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2020.115080_bb0055","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.UTI-0012-2012","article-title":"Gram-positive uropathogens, polymicrobial urinary tract infection, and the emerging microbiota of the urinary tract","volume":"4","author":"Kline","year":"2016","journal-title":"Microbiol Spectrum"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2020.115080_bb0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/jac\/dkw355","article-title":"High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii","volume":"72","author":"Lenhard","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2020.115080_bb0065","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1093\/jac\/dkz247","article-title":"Bacterial brothers in arms: cooperation of Staphylococcus aureus and Pseudomonas aeruginosa during antimicrobial exposure","volume":"74","author":"Lenhard","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2020.115080_bb0070","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/jac\/31.6.939","article-title":"Once- versus twice-daily amikacin regimen: efficacy and safety in systemic gram-negative infections. Scandinavian Amikacin Once Daily Study Group","volume":"31","author":"Maller","year":"1993","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2020.115080_bb0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clinthera.2008.01.015","article-title":"Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study","volume":"30","author":"Markou","year":"2008","journal-title":"Clin Ther"},{"issue":"20","key":"10.1016\/j.diagmicrobio.2020.115080_bb0080","doi-asserted-by":"crossref","first-page":"R686","DOI":"10.1016\/S0960-9822(02)01205-8","article-title":"Antibiotic-resistant sub-populations of the pathogenic bacterium Staphylococcus aureus confer population-wide resistance","volume":"12","author":"Massey","year":"2002","journal-title":"Curr Biol"},{"key":"10.1016\/j.diagmicrobio.2020.115080_bb0085","series-title":"Verigene Gram-negative blood culture nucleic acid test (BC-GN) package insert","author":"Nanosphere","year":"2014"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2020.115080_bb0090","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1128\/AAC.00585-11","article-title":"Genetic features of blaNDM-1-positive Enterobacteriaceae","volume":"55","author":"Poirel","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2020.115080_bb0095","first-page":"438","article-title":"Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: Systematic review and meta-analysis: mortality due to KPC Klebsiella pneumoniae infections","volume":"76","author":"Ramos-Castaneda","year":"2018","journal-title":"J Inf Secur"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2020.115080_bb0100","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02349-16","article-title":"Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant Enterobacteriaceae (CRE) in the CRE epicenter of the United States","volume":"61","author":"Satlin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2020.115080_bb0105","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02097-16","article-title":"Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections","volume":"61","author":"Shields","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2020.115080_bb0110","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0195-6701(94)90152-X","article-title":"Polymicrobial and monomicrobial bacteraemic urinary tract infection","volume":"28","author":"Siegman-Igra","year":"1994","journal-title":"J Hosp Infect"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2020.115080_bb0115","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/677157","article-title":"Rising rates of carbapenem-resistant enterobacteriaceae in community hospitals: a mixed-methods review of epidemiology and microbiology practices in a network of community hospitals in the southeastern United States","volume":"35","author":"Thaden","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2020.115080_bb0120","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02329-18","article-title":"Population pharmacokinetic analyses for plazomicin using pooled data from phase 1, 2, and 3 clinical studies","volume":"63","author":"Trang","year":"2019","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889320304570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889320304570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:53:47Z","timestamp":1760003627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889320304570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0732889320304570"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115080","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A coup d'\u00e9tat by NDM-producing Klebsiella pneumoniae overthrows the major bacterial population during KPC-directed therapy","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2020.115080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115080"}}